The effect of adding sertraline to dapoxetine in relieving sexual problems in me

Phase 3

Recruiting

Conditions: Erectile dysfunction.
Male erectile dysfunction

Registration Number: IRCT20150913024006N5

Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Male

Target Recruitment: 50

Inclusion Criteria

Erectile dysfunction anda score above 20 in the International index of Erectile Function
Treatment with phosphodiesterase 5 inhibitors (such as Sildenafil, Tadalafil) more than three months before the start of the study
Living in a stable and heterosexual relationship and intention for maintaining the relationship until the end of the study period
Possibility of sexual intercourse at least once a week

Exclusion Criteria

?Sensitivity to Selective Serotonin Reuptake Inhibitors(SSRI) drugs
Urinary tract infections
Neurological disorders
History of pelvic surgery
Underlying diseases such as diabetes, heart disease, hypertension, thyroid disorder
Use of psychiatric drugs
Alcohol consumption

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Erectile function. Timepoint: Before the intervention and 4, 8, 12 weeks after the start of the intervention. Method of measurement: Erectile Performance Index Questionnaire.;Premature ejaculation. Timepoint: Before the intervention and 4, 8, 12 weeks after the start of the intervention. Method of measurement: The interval between the beginning of sexual intercourse and the time of ejaculation in minutes in the before the intervention and 4, 8, 12 weeks after the start of the intervention.

Secondary Outcome Measures

Name	Time	Method
Premature ejaculation. Timepoint: Before the intervention and 4, 8, 12 weeks after the start of the intervention. Method of measurement: The interval between the beginning of sexual intercourse and the time of ejaculation in minutes.